Sartipy P, Camejo G, Svensson L, Hurt-Camejo E
Wallenberg Laboratory for Cardiovascular Research, Department of Heart and Lung Disease, Göteborg University, Sahlgrenska University Hospital, S-413 45 Gothenburg, Sweden.
J Biol Chem. 1999 Sep 3;274(36):25913-20. doi: 10.1074/jbc.274.36.25913.
The presence of a lipoprotein profile with abundance of small, dense low density lipoproteins (LDL), low levels of high density lipoproteins (HDL), and elevated levels of triglyceride-rich very low density lipoproteins is associated with an increased risk for coronary heart disease. The atherogenicity of small, dense LDL is believed to be one of the main reasons for this association. This particle contains less phospholipids (PL) and unesterified cholesterol than large LDL, and the apoB-100 appears to occupy a more extensive area at its surface. Although there are experiments that suggest a metabolic pathway leading to the overproduction of small, dense LDL, no clear molecular model exists to explain its association with atherogenesis. A current hypothesis is that small, dense LDL, because of its higher affinity for proteoglycans, is entrapped in the intima extracellular matrix and is more susceptible to oxidative modifications than large LDL. Here we describe how a specific reduction of approximately 50% of the PL of a normal buoyant LDL by immobilized phospholipase A(2) (PLA(2)) (EC 3.1.1.4) produces smaller and denser particles without inducing significant lipoprotein aggregation (<5%). These smaller LDL particles display a higher tendency to form nonsoluble complexes with proteoglycans and glycosaminoglycans than the parent LDL. Binding parameters of LDL and glycosaminoglycans and proteoglycans produced by human arterial smooth muscle cells were measured at near to physiological conditions. The PLA(2)-modified LDL has about 2 times higher affinity for the sulfated polysaccharides than control LDL. In addition, incubation of human plasma in the presence of PLA(2) generated smaller LDL and HDL particles compared with the control plasma incubated without PLA(2). These in vitro results indicate that the reduction of surface PL characteristic of small, dense LDL subfractions, besides contributing to its small size and density, may enhance its tendency to be retained by proteoglycans.
存在富含小而致密的低密度脂蛋白(LDL)、高密度脂蛋白(HDL)水平低以及富含甘油三酯的极低密度脂蛋白水平升高的脂蛋白谱与冠心病风险增加相关。小而致密的LDL的致动脉粥样硬化性被认为是这种关联的主要原因之一。这种颗粒比大LDL含有更少的磷脂(PL)和未酯化胆固醇,并且载脂蛋白B - 100似乎在其表面占据更广泛的区域。尽管有实验表明存在导致小而致密的LDL过度产生的代谢途径,但尚无明确的分子模型来解释其与动脉粥样硬化的关联。目前的一种假设是,小而致密的LDL由于其对蛋白聚糖的亲和力更高,被困在内膜细胞外基质中,并且比大LDL更容易发生氧化修饰。在这里,我们描述了通过固定化磷脂酶A(2)(PLA(2))(EC 3.1.1.4)将正常浮力LDL的PL特异性减少约50%如何产生更小、更致密的颗粒,而不会诱导明显的脂蛋白聚集(<5%)。这些较小的LDL颗粒与蛋白聚糖和糖胺聚糖形成不溶性复合物的倾向比亲本LDL更高。在接近生理条件下测量了人动脉平滑肌细胞产生的LDL与糖胺聚糖和蛋白聚糖的结合参数。PLA(2)修饰的LDL对硫酸化多糖的亲和力比对对照LDL高约2倍。此外,与未用PLA(2)孵育的对照血浆相比,在PLA(2)存在下孵育人血浆产生了更小的LDL和HDL颗粒。这些体外结果表明,小而致密的LDL亚组分表面PL的减少,除了有助于其小尺寸和密度外,可能会增强其被蛋白聚糖保留的倾向。